FIELD: medicine. SUBSTANCE: nonsymmetrical esters of 1,4-dehydropyridine-3,5-dicarboxylic acids were used for diabetic neuropathy treatment. EFFECT: enhanced effectiveness of agent proposed. 4 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| THERAPEUTIC AND DIETETIC COMPOSITIONS CONTAINING ESSENTIAL FATTY ACIDS AND BIOLOGICALLY ACTIVE DISULFIDES | 1998 |
|
RU2205004C2 |
| APPLICATION OF EPIDERMAL GROWTH FACTOR FOR MORPHOFUNCTIONAL RECOVERY OF PERIPHERAL NERVES IN DIABETIC NEUROPATHY | 2007 |
|
RU2460536C2 |
| METHOD FOR CREATING TRANSLATIONAL MODEL OF DIABETIC PHENOTYPE OF CHRONIC HEART FAILURE | 2023 |
|
RU2817822C1 |
| 2-AMINO-4-(4-FLUOROBENZYLAMINO)-1-ETHOXYCARBONYL-AMINOBENZENE AS ACTIVE COMPONENT OF MEDICINAL AGENT FOR PROPHYLAXIS AND TREATMENT OF RESULTS OF ACUTE AND CHRONIC CEREBRAL INSUFFICIENCY AND NEURODEGENERATIVE DISEASES ALSO (VARIANTS) | 1996 |
|
RU2201227C2 |
| APPLICATION OF RETIGABIN FOR TREATING NEUROPATHIC PAINS | 2000 |
|
RU2264813C2 |
| METHOD FOR MODELING OSTEOPOROSIS WITH STREPTOZOTOCIN-INDUCED DIABETES MELLITUS IN RATS | 2019 |
|
RU2712153C1 |
| N-[2-HYDROXY-3(1-PIPERIDINYL)-PROPOXY]-PYRIDINE-1-OXYDE-3- CARBOXYIMIDOYL CHLORIDE, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AND TREATMENT METHOD | 2000 |
|
RU2250901C2 |
| METHODS OF NEURAL DISORDER TREATMENT WITH USING HEMATOPOIETIC GROWTH FACTORS | 2003 |
|
RU2353385C2 |
| METHOD OF TREATING ENDOTHELIAL DYSFUNCTION IN DIABETES MELLITUS | 2019 |
|
RU2703567C1 |
| COMPOSITIONS AND METHODS FOR DIAGNOSTICS AND TREATMENT OF DISEASES ASSOCIATED WITH NEURITES DEGENERATION | 2013 |
|
RU2644337C2 |
